Literature DB >> 10462484

Differences in expression of pro-caspases in small cell and non-small cell lung carcinoma.

B Joseph1, J Ekedahl, F Sirzen, R Lewensohn, B Zhivotovsky.   

Abstract

Expression of several molecular determinants of apoptosis was analyzed in 10 untreated small cell (SCLC) and 6 untreated non-small cell (NSCLC) lung carcinoma cell lines. Although SCLC lines were more prone to spontaneous apoptosis compared with NSCLC lines, the former showed higher Bcl-2 expression and a higher Bcl-2/Bax ratio. In order to understand this apparent contradiction, the expression of pro-caspases as well as calpain was analyzed in these cell lines at the protein and mRNA levels. No differences in protein level of pro-caspases-2, -3, -7, and -9 and of calpain were detected between the SCLC and the NSCLC lines, but a striking difference in pro-caspase-8 expression was noted. All 6 NSCLC, but only 2 of the 10 SCLC lines, expressed pro-caspase-8 protein. Further experiments using the RNase protection assay indicated that the lack of pro-caspase-8 expression at the mRNA level was characteristic for SCLC. Using the same experimental approach, we found that SCLC cell lines in addition to pro-caspase-8 were deficient in mRNA expression of pro-caspases-1, -4, and -10, suggesting a different caspase-activating cascade in SCLC compared with NSCLC. This first systematic characterization of pro-caspase expression in lung cancer surprisingly showed that SCLC, which are more prone to undergo spontaneous apoptosis, are deficient in several pro-caspases and have a high Bcl-2/Bax ratio. Thus, the propensity of SCLC cells to undergo apoptosis cannot be explained only by the expression of factors involved in regulation or execution of apoptosis. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10462484     DOI: 10.1006/bbrc.1999.1191

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Is caspase-8 a neuroendocrine lung tumor suppressor?

Authors:  Suparna Mazumder; Alexandru Almasan
Journal:  Cancer Biol Ther       Date:  2002 Jan-Feb       Impact factor: 4.742

2.  The value of serum Bcl-2 levels in advanced lung cancer patients.

Authors:  Faruk Tas; Derya Duranyildiz; Hilal Oguz; Hakan Camlica; Ethem Nezih Oral; Vildan Yasasever; Erkan Topuz
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

3.  Cancer Immunoediting: Elimination, Equilibrium, and Immune Escape in Solid Tumors.

Authors:  Jacek R Wilczyński; Marek Nowak
Journal:  Exp Suppl       Date:  2022

4.  Doxorubicin and etoposide sensitize small cell lung carcinoma cells expressing caspase-8 to TRAIL.

Authors:  Alena Vaculova; Vitaliy Kaminskyy; Elham Jalalvand; Olga Surova; Boris Zhivotovsky
Journal:  Mol Cancer       Date:  2010-04-23       Impact factor: 27.401

5.  Inhibitor of growth 4 induces apoptosis in human lung adenocarcinoma cell line A549 via Bcl-2 family proteins and mitochondria apoptosis pathway.

Authors:  Xiaomei Li; Qingyuan Zhang; Limin Cai; Yanhua Wang; Qian Wang; Xiaoyi Huang; Songbin Fu; Jing Bai; Jinglei Liu; Guangmei Zhang; Jiping Qi
Journal:  J Cancer Res Clin Oncol       Date:  2008-11-26       Impact factor: 4.553

Review 6.  Lung cancer: a classic example of tumor escape and progression while providing opportunities for immunological intervention.

Authors:  Martin R Jadus; Josephine Natividad; Anthony Mai; Yi Ouyang; Nils Lambrecht; Sandor Szabo; Lisheng Ge; Neil Hoa; Maria G Dacosta-Iyer
Journal:  Clin Dev Immunol       Date:  2012-07-29

Review 7.  The role of mitochondria in the development and progression of lung cancer.

Authors:  Emily R Roberts; Kelly Jean Thomas
Journal:  Comput Struct Biotechnol J       Date:  2013-12-07       Impact factor: 7.271

8.  MicroRNA-related polymorphisms in apoptosis pathway genes are predictive of clinical outcome in patients with limited disease small cell lung cancer.

Authors:  Wei Jiang; Nan Bi; Wen-Jue Zhang; Li-Hong Wu; Li-Pin Liu; Yu Men; Jing-Bo Wang; Jun Liang; Zhou-Guang Hui; Zong-Mei Zhou; Lu-Hua Wang
Journal:  Oncotarget       Date:  2016-04-19

9.  The death effector domains of caspase-8 induce terminal differentiation.

Authors:  Ainhoa Mielgo; Vicente A Torres; Michael C Schmid; Ryon Graf; Samantha G Zeitlin; Pedro Lee; David J Shields; Simone Barbero; Colin Jamora; Dwayne G Stupack
Journal:  PLoS One       Date:  2009-11-18       Impact factor: 3.240

10.  FAIM2, as a novel diagnostic maker and a potential therapeutic target for small-cell lung cancer and atypical carcinoid.

Authors:  Hio Chung Kang; Jong In Kim; Hee Kyung Chang; Gavitt Woodard; Young Sik Choi; Ja-Lok Ku; David M Jablons; Il-Jin Kim
Journal:  Sci Rep       Date:  2016-09-28       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.